[Comparisons of efficacy and safety of CBV, BEAM and BEAC high-dose therapy followed by autologous hematopoietic stem cell transplantation in Hodgkin's lymphoma].
Shi YW, Liu P, Zhou SY, Yang JL, Han XH, He XH, Zhang CG, Gui L, Qin Y, Yang S, Zhao LY, Yao JR, Zhang SX, Wu SK, Pan F, Sun Y, Shi YK.
Shi YW, et al. Among authors: liu p.
Zhonghua Xue Ye Xue Za Zhi. 2017 Aug 14;38(8):716-719. doi: 10.3760/cma.j.issn.0253-2727.2017.08.013.
Zhonghua Xue Ye Xue Za Zhi. 2017.
PMID: 28954353
Free PMC article.
Chinese.
No abstract available.